Depressive Disorder News and Research

RSS

FDA accepts Labopharm's NDA for formulation of trazodone

Labopharm Inc. has announced that its New Drug Application (NDA) for the Company's novel once-daily formulation of trazodone (DDS-04A), a serotonin antagonist reuptake inhibitor (SARI), for the treatment of major depressive disorder, has been accepted for review and filed by the U.S. Food and Drug Administration (FDA).

24 Nov 2008

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

The first melatonergic antidepressant - Valdoxan/Thymanax (agomelatine) - has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) for its use in the treatment of adult patients with major depressive disorder (MDD).

21 Nov 2008

No clear evidence that depression screening improves cardiovascular patients' health

Results of a new study call into question recent clinical guidelines issued by leading cardiovascular groups, including the American Heart Association, which recommend patients with cardiovascular disease be screened for signs of depression and treated accordingly.

16 Nov 2008

MRI reveals relationship between depression and pain

The brains of individuals with major depressive disorder appear to react more strongly when anticipating pain and also display altered functioning of the neural network that modifies pain sensitivity, according to a report in the November issue of Archives of General Psychiatry , one of the JAMA/Archives journals.

4 Nov 2008

Women who smoke at risk for major depression

A new study by Australian scientists has revealed that women who smoke are at greater risk of developing a major depressive disorder.

1 Oct 2008

Cymbalta approved in Europe for generalised anxiety disorder

Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).

24 Aug 2008

Actavis receives approval of generic Wellbutrin in U.S.

Actavis Group today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.

18 Aug 2008

North Carolina mental health parity law comes into effect

North Carolina health care insurers must provide the same amount of coverage for certain mental conditions as they do for physical ailments under a state law that took effect on Tuesday, the Winston-Salem Journal reports.

3 Jul 2008

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

16 Jun 2008

Mylan announces FDA approval for generic Effexor and tentative approval for generic antihypertensive Avalide

Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base).

16 Jun 2008

UT Southwestern investigators test groundbreaking depression research in real-world setting

UT Southwestern Medical Center psychiatry researchers have taken what they learned from their groundbreaking research on treating depression and are applying it to real-world clinical settings.

15 Jun 2008

Depression in seniors linked to low levels of vitamin D

Researchers in Holland have found that older people with low blood levels of vitamin D and high blood levels of the parathyroid hormone are more likely to be depressed.

6 May 2008

Study identifies problems with diagnosis of bipolar disorder

A new study by Rhode Island Hospital and Brown University researchers reports that fewer than half the patients previously diagnosed with bipolar disorder received a diagnosis of bipolar disorder based on a comprehensive, psychiatric diagnostic interview--the Structured Clinical Interview for DSM-IV (SCID).

6 May 2008

Low blood levels of vitamin D may be associated with depression in seniors

Older adults with low blood levels of vitamin D and high blood levels of a hormone secreted by the parathyroid glands may have a higher risk of depression, according to a report in the May issue of Archives of General Psychiatry.

5 May 2008

Results of St. Jude Medical deep brain stimulation study presented at APA meeting

St. Jude Medical, Inc. today announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder.

5 May 2008

NIH study reveals incidence, precursors and psychiatric sequelae of major psychiatric disorders

A new study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) presents results on the first onset of substance use disorders (i.e., alcohol and drug abuse and dependence) and major mood and anxiety disorders, based on Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

22 Apr 2008

Depressive Disorder News and Research

FDA accepts Labopharm's NDA for formulation of trazodone

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

No clear evidence that depression screening improves cardiovascular patients' health

MRI reveals relationship between depression and pain

Women who smoke at risk for major depression

Cymbalta approved in Europe for generalised anxiety disorder

Actavis receives approval of generic Wellbutrin in U.S.

North Carolina mental health parity law comes into effect

Cymbalta approved for fibromyalgia

Mylan announces FDA approval for generic Effexor and tentative approval for generic antihypertensive Avalide

UT Southwestern investigators test groundbreaking depression research in real-world setting

Depression in seniors linked to low levels of vitamin D

Study identifies problems with diagnosis of bipolar disorder

Low blood levels of vitamin D may be associated with depression in seniors

Results of St. Jude Medical deep brain stimulation study presented at APA meeting

NIH study reveals incidence, precursors and psychiatric sequelae of major psychiatric disorders

St. Jude Medical awarded U.S. patent for neurostimulation therapy for depression

Link found between insomnia and depression in young adults

When your antidepressants don't work

Does depression lead to stroke?

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News